Total Liabilities (Quarterly) Chart

Historical Total Liabilities (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 0.0414M
March 31, 2026 0.0349M
December 31, 2025 0.031M
September 30, 2025 0.021M
June 30, 2025 0.02M
March 31, 2025 0.0304M
December 31, 2024 0.0441M
September 30, 2024 0.0157M
June 30, 2024 0.0355M
March 31, 2024 0.0217M
December 31, 2023 0.0193M
September 30, 2023 0.0193M
June 30, 2023 0.0184M
March 31, 2023 0.0146M
December 31, 2022 0.0046M
September 30, 2022 0.0046M
June 30, 2022 0.0686M
March 31, 2022 0.0757M
December 31, 2021 0.1024M
September 30, 2021 0.6636M
June 30, 2021 0.7782M
March 31, 2021
December 31, 2020 0.6626M
September 30, 2020 0.6282M
June 30, 2020 0.5466M
Date Value
March 31, 2020 0.4913M
December 31, 2019 0.4504M
September 30, 2019 0.3226M
June 30, 2019 0.3176M
March 31, 2019 0.3497M
December 31, 2018 0.2814M
September 30, 2018 0.3481M
June 30, 2018 0.3332M
March 31, 2018 0.2826M
December 31, 2017 0.2761M
September 30, 2017 0.172M
June 30, 2017 0.1796M
March 31, 2017 0.197M
December 31, 2016 0.2055M
September 30, 2016 0.364M
June 30, 2016 0.3617M
March 31, 2016 0.3331M
December 31, 2015 0.3085M
September 30, 2015 0.184M
June 30, 2015 0.1964M
March 31, 2015 1.118M
December 31, 2014 1.076M
September 30, 2014 0.1246M
June 30, 2014 0.142M
March 31, 2014 0.2799M

Total Liabilities Definition

Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.

Read full definition.

Total Liabilities (Quarterly) Range, Past 5 Years

View Total Liabilities (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Liabilities (Quarterly) Benchmarks

View Total Liabilities (Quarterly) Benchmarks
Start Trial
ANI Pharmaceuticals, Inc. 896.90M
Corcept Therapeutics, Inc. 182.93M
Veru, Inc. 8.651M
Johnson & Johnson 115.90B
Eli Lilly & Co. 108.40B

Total Liabilities (Quarterly) Related Metrics